Services on Demand
Journal
Article
Indicators
Cited by SciELO
Access statistics
Related links
Cited by Google
Similars in SciELO
Similars in Google
Share
Revista Colombiana de Cardiología
Print version ISSN 0120-5633
Abstract
HERNANDEZ-MERCADO, Marco A. et al. Post-COVID-19 sinus tachycardia: pathogenesis, identification and early stratification. Rev. Colomb. Cardiol. [online]. 2022, vol.29, n.4, pp.485-494. Epub Nov 08, 2022. ISSN 0120-5633. https://doi.org/10.24875/rccar.21000087.
COVID-19 has been responsible for a high morbi-mortality which is characterized by respiratory symptoms; its entrance to the cell is favored by angiotensin-converting enzyme 2, which is found in a variety of cells with systemic effects. The main symptoms in the cardiovascular system are: arrhythmia, heart failure, cardiogenic shock, acute coronary syndrome, bradycardia and sinus tachycardia. This disease has a prognosis that depends on genetic and demographic factors, with a progress whether to recovery, death or aftermath, then latter being described as “post-COVID-19 syndrome”. Cardiovascular compromise is reflected by the high incidence in tachycardia detected in tracing of the recovered patients of COVID-19 that refer palpitations and that during exploration of vital signs can be ascertained by an increase in heart frequency. Nevertheless its pathogenic features are still unknown, for this reason a systematic review was made with the purpose of proposing hypotheses about the physiopathological mechanisms to explain it, algorithms for early detection and a stratified treatment, so it would contribute to future investigations about the association of tachycardia as cardiovascular damage after COVID-19, due to the lack of scientific evidence in this topic.
Keywords : Post-COVID; Tachycardia; COVID-19; SARS-CoV-2.